Whitehawk Therapeutics (WHWK) Competitors $1.92 -0.05 (-2.54%) As of 09/19/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock WHWK vs. KRRO, ALT, FDMT, UPXI, TECX, LRMR, GALT, AMRN, FHTX, and OCGNShould you be buying Whitehawk Therapeutics stock or one of its competitors? The main competitors of Whitehawk Therapeutics include Korro Bio (KRRO), Altimmune (ALT), 4D Molecular Therapeutics (FDMT), Upexi (UPXI), Tectonic Therapeutic (TECX), Larimar Therapeutics (LRMR), Galectin Therapeutics (GALT), Amarin (AMRN), Foghorn Therapeutics (FHTX), and Ocugen (OCGN). These companies are all part of the "pharmaceutical products" industry. Whitehawk Therapeutics vs. Its Competitors Korro Bio Altimmune 4D Molecular Therapeutics Upexi Tectonic Therapeutic Larimar Therapeutics Galectin Therapeutics Amarin Foghorn Therapeutics Ocugen Korro Bio (NASDAQ:KRRO) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, media sentiment, institutional ownership, valuation and profitability. Does the media favor KRRO or WHWK? In the previous week, Korro Bio had 2 more articles in the media than Whitehawk Therapeutics. MarketBeat recorded 2 mentions for Korro Bio and 0 mentions for Whitehawk Therapeutics. Korro Bio's average media sentiment score of 0.83 beat Whitehawk Therapeutics' score of 0.00 indicating that Korro Bio is being referred to more favorably in the media. Company Overall Sentiment Korro Bio Positive Whitehawk Therapeutics Neutral Which has better earnings and valuation, KRRO or WHWK? Whitehawk Therapeutics has higher revenue and earnings than Korro Bio. Whitehawk Therapeutics is trading at a lower price-to-earnings ratio than Korro Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKorro Bio$2.27M149.12-$83.58M-$9.75-3.70Whitehawk Therapeutics$25.98M3.48-$63.69M-$0.06-32.00 Is KRRO or WHWK more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to Korro Bio's net margin of 0.00%. Korro Bio's return on equity of -61.51% beat Whitehawk Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Korro BioN/A -61.51% -42.87% Whitehawk Therapeutics 99.42%-75.99%-68.57% Do institutionals and insiders believe in KRRO or WHWK? 13.2% of Korro Bio shares are held by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are held by institutional investors. 4.6% of Korro Bio shares are held by company insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, KRRO or WHWK? Korro Bio has a beta of 2.66, suggesting that its stock price is 166% more volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Do analysts rate KRRO or WHWK? Korro Bio presently has a consensus target price of $86.83, indicating a potential upside of 140.87%. Given Korro Bio's stronger consensus rating and higher possible upside, equities analysts clearly believe Korro Bio is more favorable than Whitehawk Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Korro Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29Whitehawk Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryKorro Bio beats Whitehawk Therapeutics on 11 of the 17 factors compared between the two stocks. Get Whitehawk Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WHWK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding WHWK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WHWK vs. The Competition Export to ExcelMetricWhitehawk TherapeuticsPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$92.84M$858.70M$2.54B$10.40BDividend YieldN/A4.84%2.49%4.60%P/E Ratio-32.001.2126.3926.75Price / Sales3.4826.44119.04124.23Price / CashN/A19.5650.6161.55Price / Book0.916.7036.236.40Net Income-$63.69M-$4.03M$14.01M$271.62M7 Day Performance-3.52%-1.27%5.35%3.46%1 Month Performance16.36%7.66%9.09%9.87%1 Year PerformanceN/A16.40%70.30%28.45% Whitehawk Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WHWKWhitehawk TherapeuticsN/A$1.92-2.5%N/AN/A$92.84M$25.98M-32.0021KRROKorro Bio1.9113 of 5 stars$35.51-1.7%$86.83+144.5%-6.4%$339.20M$2.27M-3.6470Positive NewsALTAltimmune2.5527 of 5 stars$3.67-2.9%$17.40+374.1%-50.1%$333.61M$20K-3.1150Trending NewsFDMT4D Molecular Therapeutics2.4727 of 5 stars$6.94-0.4%$30.40+338.0%-51.1%$325.52M$40K-1.97120UPXIUpexi3.069 of 5 stars$5.46-0.7%$15.50+183.9%+55.7%$323.89M$26M0.00130Positive NewsTECXTectonic Therapeutic3.1214 of 5 stars$17.31+0.5%$80.29+363.8%-24.3%$322.22MN/A-4.28120Positive NewsLRMRLarimar Therapeutics2.6778 of 5 stars$4.00+3.4%$18.43+360.7%-41.2%$320.35MN/A-2.5630Positive NewsGALTGalectin Therapeutics1.7593 of 5 stars$5.00+1.0%$6.00+20.0%+69.0%$317.10MN/A-7.819AMRNAmarin0.5503 of 5 stars$14.99-1.5%$12.00-19.9%+28.2%$314.79M$228.61M-4.08360FHTXFoghorn Therapeutics2.8439 of 5 stars$5.15-5.2%$10.67+107.1%-48.1%$306.96M$22.60M-4.33120Trending NewsAnalyst UpgradeAnalyst RevisionOCGNOcugen1.6586 of 5 stars$1.04+1.0%$6.00+476.9%+17.5%$301.07M$4.05M-5.2080News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies KRRO Competitors ALT Competitors FDMT Competitors UPXI Competitors TECX Competitors LRMR Competitors GALT Competitors AMRN Competitors FHTX Competitors OCGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:WHWK) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Whitehawk Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Whitehawk Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
